Comparable TNF-alpha, IFN-gamma and GM-CSF production by purified normal marrow CD3 cells in response to horse anti-lymphocyte and rabbit antithymocyte globulin

European Journal of Haematology

Volumn 60, Issue 4, 1998, Pages 240-244

  Piaggio, G ^a   Podesta M ^a   Pitto, A ^a   Pittaluga, G B ^a   Isaza, A ^a   Benvenuto, F ^a   Bruno, B ^a   Bacigalupo, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Antilymphocyte globulin; Antithymocyte globulin; Aplastic anaemia

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LYMPHOCYTE ANTIBODY; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

APLASTIC ANEMIA; ARTICLE; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOTHERAPY; INTERFERON PRODUCTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; T LYMPHOCYTE ACTIVATION;

EID: 0031971181     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01030.x     Document Type: Article

References (15)

1. YOUNG NS, MACIEJEWSKI J. Mechanisms of disease: the pathophysiology of acquired anemia. N Engl J Med 1997: 19: 1365-1372.
2. SPECK B, GLUCKMAN E. HAAK HL, VAN ROOD JJ. Treatment of aplastic anemia by antilymphocyte globulin with and without allogeneic bone marrow infusion. Lancet 1977: ii: 1145-1147.
3. FRICKHOFEN N, KALTWASSER JP, SCHREZENMEIER H, et al. Treatment of aplastic anemia with antithymocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 1991: 324: 1297-1304.
4. PLATANIAS L, GASCON P, BIELORY L, GRIFFITH P, NIENHUIS AW, YOUNC, N. Lymphocyte subsets and lymphokines following antithymocyte globulins therapy in patients with aplastic anemia. Br J Haematol 1978: 66: 433-443.
5. TENAMURA M, KOBAYASHI S, IWABE K, YOSHINAGA K, MIZOGUCHI H. Mechanism of action of antithymocyte globulin in the treatment of aplastic anaemia: in vitro evidence for the presence of immunosuppressive mechanism. Br J Haematol 1997: 96: 80-84.
6. KAWANO Y, NISSEN C. GRATWOHL A, WURSCH A, SPECK B. Cytotoxic and stimulatory effects of antilymphocyte globulin (ALG) on hematopoiesis. Blut 1990: 60: 297-300.
7. TONG J, BACIGALUPO A, PIAGGIO G, FIGARI O, SOGNO G, MARMONT AM. In vitro response of T cells from aplastic anemia patients to antilymphocyte globulin and phytohemoagglulinin: colony-stimulating activity and lymphokine production. Exp Haematol 1991: 19: 312-316.
8. NIMER SD, GOLDE DW, KWAN K, LEE K. CLARK S, CHAMPLIN R. In vitro production of granulocytemacrophage colony stimulating factor in aplastic anemia: possible mechanisms of action of antithymocyte globulin. Blood 1991: 78: 163-168.
9. KAWANO Y, NISSEN C, GRATWOHL A, SPECK B. Immunostimulalory effects of different antilymphocyte globulin preparations: a possible clue to their clinical effect. Br J Haematol 1988: 68: 115-121.
10. DONEY K, MARTIN P, STORB R. et al. A randomised trial of antihuman thymocyte globulin versus murine monoclonal antihuman T-cell antibodies as immunosuppressive therapy for aplastic anemia. Exp Haematol 1985: 13: 520-524.
11. RAEFSKY E, GASCON P, GRATWOHL A, SPECK B, YOUNG NS. Biological and biochemical characterization of antithymocyte globulins (ATG) and anti-lymphocyte globulins (ALG). Blood 1986: 66: 721-723.
12. SMITH AG, O'REILLY RJ. HANSEN JA, MARTIN PJ. Specific antibody-blocking activities in antilymphocyte globulin as correlates of efficacy for the treatment for aplastic anemia. Blood 1985: 66: 721-723.
13. MARMOM AM, BACIGALLUPO A, PODESTÀ M, et al. Treatment of severe aplastic anemia with sequential immunosuppression. Exp Haematol 1983: 11: 856-861.
14. NISSEN C, MOSER Y, WEIS J, WURSCH A, GRATWOHL A, SPECK B. The release of interleukin-2 (IL-2) and colony stimulating activity (CSA) in aplastic anemia patients: opposite behaviour with improvement of bone marrow function. Blut 1986: 52: 221-230.
15. BACIGALLUPO A, BROCCIA G, CORDA A, et al. Antilymphocyte globulin, cyclosporin and granulocyte stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA working party. Blood 1995: 85: 5: 1348-1353.